Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
75
EXPE Quote, Financials, Valuation and Earnings
Last price:
$155.12
Seasonality move
:
12.87%
Day range:
$157.65 - $162.14
52-week range:
$107.25 - $207.73
Dividend yield:
0.25%
P/E ratio:
17.70x
P/S ratio:
1.59x
P/B ratio:
13.25x
Volume:
2.2M
Avg. volume:
2.4M
1-year change:
17.19%
Market cap:
$20.6B
Revenue:
$13.7B
EPS (TTM):
$9.05
Analysts' Opinion
-
Consensus RatingExpedia Group has received a consensus rating of Hold. The company's average rating is a Hold based on 12 Buy ratings, 21 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $201.69, Expedia Group has an estimated upside of 25.94% from its current price of $160.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $143.00 representing 10.71% downside risk from its current price of $160.15.
Fair Value
-
According to the consensus of 34 analysts, Expedia Group has 25.94% upside to fair value with a price target of $201.69 per share.
EXPE vs. S&P 500
-
Over the past 5 trading days, Expedia Group has overperformed the S&P 500 by 3.29% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Expedia Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Expedia Group has grown year-over-year revenues for 15 quarters straight. In the most recent quarter Expedia Group reported revenues of $3.2B.
Earnings Growth
-
Expedia Group has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Expedia Group reported earnings per share of $2.20.
Enterprise value:
23.7B
EV / Invested capital:
--
Price / LTM sales:
1.59x
EV / EBIT:
13.23x
EV / Revenue:
1.73x
PEG ratio (5yr expected):
0.26x
EV / Free cash flow:
10.16x
Price / Operating cash flow:
9.37x
Enterprise value / EBITDA:
9.01x
Gross Profit (TTM):
$12.2B
Return On Assets:
5.23%
Net Income Margin (TTM):
9.01%
Return On Equity:
49.71%
Return On Invested Capital:
14.12%
Operating Margin:
11.18%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $11.7B | $12.8B | $13.7B | $2.9B | $3.2B | |
| Gross Profit | $10B | $11.3B | $12.2B | $2.5B | $2.8B | |
| Operating Income | $1.2B | $1.5B | $1.7B | $220M | $356M | |
| EBITDA | $1.6B | $2.1B | $2.6B | $440M | $609M | |
| Diluted EPS | $2.14 | $5.38 | $9.05 | $0.92 | $2.20 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.6B | $8.2B | $8.8B | $9.2B | $9.8B | |
| Total Assets | $18.7B | $21.5B | $21.6B | $21.6B | $22.4B | |
| Current Liabilities | $5.4B | $9.5B | $10.8B | $11.8B | $13.6B | |
| Total Liabilities | $14.7B | $18B | $17.8B | $18.9B | $19.6B | |
| Total Equity | $4B | $3.6B | $3.7B | $2.8B | $2.8B | |
| Total Debt | $8.2B | $8.5B | $6.2B | $6.3B | $6.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.4B | $2.7B | $3.1B | -$238M | $198M | |
| Cash From Investing | -$580M | -$800M | -$1.3B | -$165M | -$361M | |
| Cash From Financing | -$2.6B | -$2.1B | -$1.7B | -$497M | -$155M | |
| Free Cash Flow | $2.8B | $1.8B | $2.3B | -$415M | $7M | |
EXPE
Sector
Market Cap
$20.6B
$401M
Price % of 52-Week High
77.1%
66.47%
Dividend Yield
0.25%
0%
Shareholder Yield
7.65%
3.88%
1-Year Price Total Return
17.19%
-17.67%
Beta (5-Year)
1.653
0.832
Dividend yield:
0.25%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$156.01
200-day SMA
Sell
Level
$162.26
Bollinger Bands (100)
Sell
Level
160.97 - 193.59
Chaikin Money Flow
Buy
Level
284.5M
20-day SMA
Buy
Level
$153.47
Relative Strength Index (RSI14)
Buy
Level
50.77
ADX Line
Sell
Level
19.96
Williams %R
Sell
Level
-13.034
50-day SMA
Sell
Level
$170.94
MACD (12, 26)
Sell
Level
-2.61
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
296.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4443)
Sell
CA Score
(Annual)
Level (-1.8284)
Buy
Beneish M-Score
(Annual)
Level (-2.7644)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.467)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Stock Forecast FAQ
In the current month, EXPE has received 12 Buy ratings 21 Hold ratings, and 1 Sell ratings. The EXPE average analyst price target in the past 3 months is $201.69.
-
Where Will Expedia Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Expedia Group share price will rise to $201.69 per share over the next 12 months.
-
What Do Analysts Say About Expedia Group?
Analysts are divided on their view about Expedia Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Expedia Group is a Sell and believe this share price will drop from its current level to $143.00.
-
What Is Expedia Group's Price Target?
The price target for Expedia Group over the next 1-year time period is forecast to be $201.69 according to 34 Wall Street analysts, 12 of them rate the stock a Buy, 1 rates the stock a Sell, and 21 analysts rate the stock a Hold.
-
Is EXPE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Expedia Group is a Hold. 21 of 34 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of EXPE?
You can purchase shares of Expedia Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Expedia Group shares.
-
What Is The Expedia Group Share Price Today?
Expedia Group was last trading at $155.12 per share. This represents the most recent stock quote for Expedia Group. Yesterday, Expedia Group closed at $160.15 per share.
-
How To Buy Expedia Group Stock Online?
In order to purchase Expedia Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
